Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q2)Sep 30, 2025 | (Q1)Jun 30, 2025 | (FY)Mar 31, 2025 | (Q4)Mar 31, 2025 | (Q3)Dec 31, 2024 | (Q2)Sep 30, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 98.73%-4.83K | -322.89%-1.28M | 18.25%-1.62M | -55.30%-699.45K | 37.55%-236.6K | 44.97%-381.61K | 34.07%-303.62K | 77.63%-1.98M | 74.55%-450.39K | 86.49%-378.87K |
| Net income from continuing operations | -648.88%-2.58M | -180.81%-1.39M | 12.09%-3.42M | -52.83%-1.39M | -120.79%-1.19M | 53.85%-345.05K | 70.84%-494.93K | 68.10%-3.9M | 86.52%-910.22K | 78.75%-540.65K |
| Operating gains losses | ---- | ---- | --4.65K | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Asset impairment expenditure | ---- | ---- | --0 | ---- | ---- | ---- | ---- | -88.57%650K | ---- | ---- |
| Unrealized gains and losses of investment securities | -91.79%1.23K | -99.88%186 | -83.93%184.43K | 99.93%-75 | -62.86%19.5K | -80.00%15K | -86.67%150K | 202.00%1.15M | 86.27%-105K | -41.67%52.5K |
| Remuneration paid in stock | --1.23M | --331.89K | --1.38M | --508.4K | --874.47K | --0 | --0 | --0 | --0 | ---- |
| Other non cashItems | 43.94%50.45K | -14.88%36.29K | 287.41%171.4K | 298.57%43.16K | 1,204.98%50.57K | 127.01%35.05K | 202.33%42.63K | 105.22%44.24K | 132.02%10.83K | 101.59%3.88K |
| Change In working capital | 1,596.58%1.3M | -19,732.70%-262.59K | -15.07%60.18K | 241.18%135.53K | -88.06%12.58K | -139.47%-86.61K | -101.36%-1.32K | 120.86%70.86K | -490.83%-96K | 198.05%105.41K |
| -Change in receivables | -3,357.22%-32.57K | -324.35%-24.01K | -141.87%-39.32K | -72.81%-17.12K | -243.24%-31.97K | -106.24%-942 | -83.88%10.7K | 435.61%93.92K | -107.35%-9.91K | 122.32%22.32K |
| -Change in prepaid assets | -2,865.43%-467.59K | -504.96%-58.99K | -398.51%-44.85K | -1,251.81%-57.64K | -34.41%13.99K | -17.87%-15.77K | 28.50%14.57K | -84.09%15.03K | -105.11%-4.26K | -77.96%21.33K |
| -Change in payables and accrued expense | 2,669.94%1.8M | -575.28%-179.58K | 479.00%144.36K | 356.99%210.29K | -50.52%30.56K | -84.48%-69.9K | -233.85%-26.59K | 91.57%-38.09K | 57.76%-81.83K | 159.21%61.76K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 98.73%-4.83K | -322.89%-1.28M | 18.25%-1.62M | -55.30%-699.45K | 37.55%-236.6K | 44.97%-381.61K | 34.07%-303.62K | 77.63%-1.98M | 74.55%-450.39K | 86.49%-378.87K |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -2,683.56%-695.89K | -575.16K | -738.66%-209.66K | -269.33%-184.66K | 0 | 0.00%-25K | 0 | 93.25%-25K | 0.00%-50K | 0 |
| Net PPE purchase and sale | -2,966.78%-766.7K | ---575.16K | -212.96%-234.72K | -39.81%-209.72K | --0 | 0.00%-25K | --0 | 79.17%-75K | -200.00%-150K | --50K |
| Net investment purchase and sale | ---- | ---- | --25.05K | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net other investing changes | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 814.29%50K | --100K | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | -2,683.56%-695.89K | ---575.16K | -738.66%-209.66K | -269.33%-184.66K | --0 | 0.00%-25K | --0 | 93.25%-25K | 0.00%-50K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -462.01K | 3.21M | 37.12%2.42M | 60.72%2.04M | 12,670.02%381.5K | 0 | 0 | 10.25%1.77M | 1.27M | 94.94%-3.04K |
| Net issuance payments of debt | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- |
| Net common stock issuance | ---963K | --3.19M | 14.04%2.02M | 28.13%1.63M | --390.5K | --0 | --0 | 17.21%1.78M | --1.28M | --0 |
| Proceeds from stock option exercised by employees | --551.33K | --89.64K | --425.45K | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Net other financing activities | ---50.34K | ---65.2K | -260.71%-25.23K | -309.90%-16.23K | ---- | ---- | ---- | 85.55%-6.99K | ---3.96K | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | ---462.01K | --3.21M | 37.12%2.42M | 60.72%2.04M | 12,670.02%381.5K | --0 | --0 | 10.25%1.77M | --1.27M | 94.94%-3.04K |
| Net cash flow | ||||||||||
| Beginning cash position | 438.69%2.76M | 72.68%1.41M | -22.72%816.62K | 447.91%251.29K | -75.13%106.38K | -20.62%512.99K | -22.72%816.62K | -87.84%1.06M | -98.41%45.86K | -92.55%427.77K |
| Current changes in cash | -185.96%-1.16M | 545.70%1.35M | 347.16%593.53K | 50.35%1.16M | 137.94%144.9K | -86.14%-406.61K | 26.04%-303.62K | 96.85%-240.14K | 142.35%770.75K | 86.67%-381.9K |
| End cash Position | 1,404.64%1.6M | 438.69%2.76M | 72.68%1.41M | 72.68%1.41M | 447.91%251.29K | -75.13%106.38K | -20.62%512.99K | -22.72%816.62K | -22.72%816.62K | -98.41%45.86K |
| Free cash from | -89.75%-771.53K | -512.33%-1.86M | 9.83%-1.86M | -73.05%-909.17K | 33.14%-236.6K | 43.40%-406.61K | 34.07%-303.62K | 77.69%-2.06M | 71.13%-525.39K | 87.38%-353.87K |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.